Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects
Diego Gomes Kjerulf, Shari Wang, Mohamed Omer, Asha Pathak, Savitha Subramanian, Chang Yeop Han, Chongren Tang, Laura J. den Hartigh, Baohai Shao, Alan Chait
Topics & Concepts
GlycationInternal medicineEndocrinologyDiabetes mellitusMedicineCholesterolReverse cholesterol transportIn vivoLipoproteinBiologyBiotechnologyAdvanced Glycation End Products researchDiabetes, Cardiovascular Risks, and LipoproteinsNatural Antidiabetic Agents Studies